Regience Japan

[ShookOnes]

i'm not optimistic or pessimistic, i skip speculation and just look at the news on forums. I always find optimism trolls and pessimism trolls they both share not being scientist in common. or quoting their dr. or some spammy HT clinic etc. i'm starting to doubt both sides now. but what wakes you up in the morning to get on hair loss forums are you really that unoccupied that you find yourself expecting something in 20 years? I'm psyched about virtual reality but i wasn't on blogs in 1995 telling everyone how premature their excitement was.

On fin and had 1600 fue I couldn't care less if a cure took 40 years lol. I'm expecting 20 because it's realistic looking at how far we are today. 20 years would be fantastic imo.

[ShookOnes]

Regience will clearly be the strongest competitor for Shiseido at near term, maybe even his assassin

July2015
http://webcache.googleusercontent.co...&ct=clnk&gl=fr


Japan is working hard on regenerative medicine. The development of cell and tissue regeneration is one of the pillars of the Growth Strategy in Japan and the government is pushing projects to improve competitiveness of this growing industry. The legislation for pharmaceutical and medical device was revised last fall to enable shorten the approval processes for commercialization. A new Agency for Medical Research and Development (AMED, 1) was also established in April 2015 for better crossovers between relevant ministries and strengthen support system of network in the development process. Benefiting from these movements, major pharmaceutical companies and other industries, such as Fujifilm and Nikon are actively investing and collaborating with overseas companies. In June 2015, the ten key companies formed a task force to establish a regenerative médicine development center and are inviting biotech companies from overseas

The regenerative medicine is a pillar of growth strategy in Japan and the government is pushing projects in the development of new drugs and technology to improve competitiveness of this growing industry. The revision of pharmaceutical and medical device law enforced last November and a new approval system was established for priority review and approval for innovative products. As the regenerative medicine receives high expectations for practical application, the new system will shorten the approval for commercialization as little as three to four years including development after meeting the safety requirements which shortened by approximately six years compared to decades ago. This revision of the law created a separate regulatory pathway for medical devices and could lead less complex approval procedures for some foreign manufacturers.

In addition to major pharmaceutical and medical device companies, other industries and venture businesses are entering the market. Japanese companies have been aggressively taking over foreign companies. For example, Fujifilm acquired U.S. based developer and manufacturer, of fully functioning human cells in industrial quantities to precise specifications, Cellular Dynamics International, Inc. in March 15. Nikon and Lonza of Switzerland agreed to collaborate for cell and gene therapy manufacturing in Japan in May 2015. Olympus and Mitsubishi Chemical HD also established regenerative medicine units within the organization to expand the opportunities


Regenerative Medicine Industrialization Task Force (RMIT) announced its plan of ten companies from Japan and abroad to establish a regenerative medicine development center in Kawasaki city in 2017. They are inviting overseas biotech companies to join and collaborate, to pool the technologies and provide regenerative medicine treatments using cultured cells, in order to lead the development and commercialization of regenerative medicine.

The ten companies are; Fujifilm, Astellas Pharma, Janssen Pharma, Regience, Rohto Pharmaceutical, Cell Seed, Wako Pure Chemical, Takara Bio,Tella, MediNet (4). The major areas of the development are cell processing and culturing, cell sheet, material, equipment, reagent and pharmaceutical. The taskforce was established within the Forum for Innovative Regenerative Medicine (FIRM, 5) in Japan which has over 150 member companies.

Taking the advantage of these movements in Japan, the plan of the taskforce companies is to actively promote regenerative medicine technologies to overseas from Japan. The development center will be built in the special economic zone in Kawasaki, “Keihin life innovation international strategic zone” in neighboring city of Tokyo (6). The life innovation international center will open in Spring 2016

The global market for regenerative medicine estimated by Ministry of Economy, Trade and Industry (METI), amounts to an annual 100 billion yen ($811 million), and expects to grow rapidly to 1 trillion yen in 2020, and 12 trillion yen in 2030

Id say this is the best news of 2016 unless some crazy news comes out from congress. Nice find Laz.

[burtandernie]

In 5 years you're going to be very disappointed.

I think in 5 years we will have 1 or more treatments similar in effectiveness to what exists right now. I think MPB is going to turn into a thing where your using 5 different things together that cost a fortune to regrow some and keep what you have better than your able to right now. A cure in 5 years would surprise me. My guess is more like 20+ or longer maybe not in our lifetimes. Keeping what you have is the cure in the near future.

[ShookOnes]

I think in 5 years we will have 1 or more treatments similar in effectiveness to what exists right now. I think MPB is going to turn into a thing where your using 5 different things together that cost a fortune to regrow some and keep what you have better than your able to right now. A cure in 5 years would surprise me. My guess is more like 20+ or longer maybe not in our lifetimes. Keeping what you have is the cure in the near future.

well in 5 years it def should be since cb0301 is projected for 2021 right? And sm may or may not come out around that time. I don't think you'd need 5 different things when those 2 with/without fin would probably be enough to maintain/regrow. 20+ is also what I think is possible.

[jpar]

Shook i hard that CB was tested by a bunch of people already the past few years and they all say its totally worthless.

[jpar]

well in 5 years it def should be since cb0301 is projected for 2021 right? And sm may or may not come out around that time. I don't think you'd need 5 different things when those 2 with/without fin would probably be enough to maintain/regrow. 20+ is also what I think is possible.

Not to sound consdescending but, yeah CB is not a cure, SM is interestign but remains to be seen.. and Shiseido said themselves they hope to commercialize in 2018, those teams of scientist are at least more educated and that is not to say Replicel/Shiseido = Cure it's a treatment not a cure.

finesteride is great but my penis wouldn't get hard after 6 days It returned. It was one of the most terrifying experiences of my life. So not everyone can get on that stuff you know.

[ShookOnes]

Damn was hoping the company would tweak their product. Wasn't condescending at all. And yeah there'll be products in 5 years, maybe histogen and replicel will be available but I'm honestly not too optimistic on their outcome.

Could be because I'm a diffuser who started balding at 14 and bitter as **** for the last 8 years, lol.